Barnett H J, Taylor D W, Eliasziw M, Fox A J, Ferguson G G, Haynes R B, Rankin R N, Clagett G P, Hachinski V C, Sackett D L, Thorpe K E, Meldrum H E, Spence J D
John P. Robarts Research Institute, London, ON, Canada.
N Engl J Med. 1998 Nov 12;339(20):1415-25. doi: 10.1056/NEJM199811123392002.
Previous studies have shown that carotid endarterectomy in patients with symptomatic severe carotid stenosis (defined as stenosis of 70 to 99 percent of the luminal diameter) is beneficial up to two years after the procedure. In this clinical trial, we assessed the benefit of carotid endarterectomy in patients with symptomatic moderate stenosis, defined as stenosis of less than 70 percent. We also studied the durability of the benefit of endarterectomy in patients with severe stenosis over eight years of follow-up.
Patients who had moderate carotid stenosis and transient ischemic attacks or nondisabling strokes on the same side as the stenosis (ipsilateral) within 180 days before study entry were stratified according to the degree of stenosis (50 to 69 percent or <50 percent) and randomly assigned either to undergo carotid endarterectomy (1108 patients) or to receive medical care alone (1118 patients). The average follow-up was five years, and complete data on outcome events were available for 99.7 percent of the patients. The primary outcome event was any fatal or nonfatal stroke ipsilateral to the stenosis for which the patient underwent randomization.
Among patients with stenosis of 50 to 69 percent, the five-year rate of any ipsilateral stroke (failure rate) was 15.7 percent among patients treated surgically and 22.2 percent among those treated medically (P=0.045); to prevent one ipsilateral stroke during the five-year period, 15 patients would have to be treated with carotid endarterectomy. Among patients with less than 50 percent stenosis, the failure rate was not significantly lower in the group treated with endarterectomy (14.9 percent) than in the medically treated group (18.7 percent, P=0.16). Among the patients with severe stenosis who underwent endarterectomy, the 30-day rate of death or disabling ipsilateral stroke persisting at 90 days was 2.1 percent; this rate increased to only 6.7 percent at 8 years. Benefit was greatest among men, patients with recent stroke as the qualifying event, and patients with hemispheric symptoms.
Endarterectomy in patients with symptomatic moderate carotid stenosis of 50 to 69 percent yielded only a moderate reduction in the risk of stroke. Decisions about treatment for patients in this category must take into account recognized risk factors, and exceptional surgical skill is obligatory if carotid endarterectomy is to be performed. Patients with stenosis of less than 50 percent did not benefit from surgery. Patients with severe stenosis (> or =70 percent) had a durable benefit from endarterectomy at eight years of follow-up.
既往研究表明,有症状的重度颈动脉狭窄(定义为管腔直径狭窄70%至99%)患者行颈动脉内膜切除术,术后两年内有益。在这项临床试验中,我们评估了有症状的中度狭窄(定义为狭窄小于70%)患者行颈动脉内膜切除术的益处。我们还研究了重度狭窄患者内膜切除术后八年益处的持续性。
在研究入组前180天内有中度颈动脉狭窄且在狭窄同侧(患侧)发生短暂性脑缺血发作或非致残性卒中的患者,根据狭窄程度(50%至69%或<50%)进行分层,并随机分配接受颈动脉内膜切除术(1108例患者)或仅接受药物治疗(1118例患者)。平均随访时间为五年,99.7%的患者可获得结局事件的完整数据。主要结局事件是患者因随机分组所针对的狭窄同侧发生的任何致命或非致命性卒中。
在狭窄程度为50%至69%的患者中,手术治疗组五年内任何患侧卒中发生率(失败率)为15.7%,药物治疗组为22.2%(P = 0.045);为预防五年内一次患侧卒中,需对15例患者行颈动脉内膜切除术。在狭窄程度小于50%的患者中,内膜切除术治疗组的失败率(14.9%)并不显著低于药物治疗组(18.7%,P = 0.16)。在接受内膜切除术的重度狭窄患者中,术后30天内死亡或至90天时仍存在的致残性患侧卒中发生率为2.1%;至8年时该发生率仅增至6.7%。益处最大的是男性、以近期卒中作为符合条件事件的患者以及有半球症状的患者。
有症状的中度颈动脉狭窄(50%至69%)患者行内膜切除术仅能适度降低卒中风险。对此类患者的治疗决策必须考虑公认的危险因素,若要进行颈动脉内膜切除术,精湛的手术技巧必不可少。狭窄程度小于50%的患者未从手术中获益。重度狭窄(≥70%)患者在长达八年的随访中从内膜切除术中持续获益。